Janssen Therapeutics
Manufacturing · 11-50 Employees
View Company Info for Free
Overview
Phone Number
(800) 526-7736Website
www.symtuzahcp.comRevenue
$7.2 MillionIndustry
ZI Rank: 1
Signal Type
Jan
Feb
Mar
Apr
May
Jun
ZI Rank
1
1
1
1
1
1
About Janssen Therapeutics
SYMTUZA offers a single-tablet regimen combining darunavir, cobicistat, emtricitabine, and tenofovir alafenamide for the treatment of HIV-1. The product is designed for both treatment-naïve and treatment-experienced patients, emphasizing sustained tolerability and proven efficacy. The company provides resources for healthcare professionals and patients, including prescribing information and support for treatment decisions. SYMTUZA aims to simplify antiretroviral therapy and improve patient satisfaction while addressing safety and tolerability concerns.Explore more
Popular SearchesJanssen TherapeuticsSymtuzaJanssen Products LPSIC Code 28,283NAICS Code 32,325Show more
Janssen Therapeutics Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Janssen Therapeutics your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Click to see if Janssen Therapeutics had a recent Job posting/layoffs
Funding: Get notified immidiatlly once Janssen Therapeutics has new funding data
Earning: See what the market has to say on Janssen Therapeutics recently announced quarterly report
Product Launch: Get notified when Janssen Therapeutics launches new products
Check if Janssen Therapeutics has recently received funding, and reach out quickly before it becomes old news!
Website visits: Recent activity has been detected on your website
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Congratulate Masked Content for being promoted to Masked Content at Janssen Therapeutics
Janssen Therapeutics, which may be a good buyer, showed buying intent in Masked Content Topic
Check out if Janssen Therapeutics is spiking on competitors!
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find more new buyers
Compare Similar Companies to Janssen Therapeutics
Compare insights from companies similar to Janssen Therapeutics, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Janssen Therapeutics is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Janssen Therapeutics is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Janssen Therapeutics.
Janssen Therapeutics Tech Stack
A closer look at the technologies used by Janssen Therapeutics
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Janssen Therapeutics
Sign Up For FreeTo access detailed company insights
SYMTUZA offers a single-tablet regimen combining darunavir, cobicistat, emtricitabine, and tenofovir alafenamide for the treatment of HIV-1. The product is designed for both treatment-naïve and treatment-experienced patients, emphasizing sustained tolerability and proven efficacy. The company provides resources for healthcare professionals and pati... Read More
